Counseling and testing for HIV prevention: Costs, effects, and cost-effectiveness of more rapid screening tests

Public Health Reports

Volumn 111, Issue 1, 1996, Pages 44-53

  Farnham, Paul G ^a,b   Gorsky, Robin D ^d   Holtgrave, David R ^a,c   Jones, Wanda K ^e   Guinan, Mary E ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF NEW HAMPSHIRE   (United States)

^e CDC

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; COST EFFECTIVENESS ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COUNSELING; PRIORITY JOURNAL; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE;

AIDS SERODIAGNOSIS; ALGORITHMS; COST-BENEFIT ANALYSIS; COUNSELING; DECISION SUPPORT TECHNIQUES; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); SENSITIVITY AND SPECIFICITY;

EID: 0030059772     PISSN: 00333549     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention. Publicly funded HIV counseling and testing - United States, 1991. MMWR 1992; 41:613-617.
2. George JR, Schochetman G. Detection of HIV Infection Using Serologic Techniques. in AIDS Testing: A Comprehensive Guide to Technical, Medical, Social, Legal, and Management Issues, 2nd ed. G Schochetman and JR George, eds. New York: Springer-Verlag, 1994, 62-102.
3. Centers for Disease Control and Prevention. External Review of CDC's HIV Prevention Strategies by the CDC Advisory Committee on the Prevention of HIV Infection. Washington, DC: US Government Printing Office, 1994.
4. Valdiserri, RO, Moore M, Gerber AR, Campbell CH, Dillon BA, West GR. A study of clients returning for counseling after HIV testing: Implications for improving rates of return. Public Health Reports 1993;108:12-18.
5. Doll LS, Kennedy MB. HIV counseling and testing: What is it and how well does it work? in AIDS Testing. A Comprehensive Guide to Technical, Medical, Social, Legal, and Management Issues, 2nd ed. G Schochetman and JR George, eds. New York: Springer-Verlag, 1994, 302-319.
6. Squire SB, Elford J, Bor R, et al. Open access clinic providing HIV-I antibody results on day of testing: the first twelve months. British Medical Journal 1991;302:1383-1386.
7. Morris DJ, Corbitt G, Crosdale E. Same-day testing for human immunodeficiency virus antibodies. Journal of Virological Methods 1994;49:367-370.
8. Kassler WJ, Dillon B, Haley C, et al. HIV prevention counseling using an on-site rapid HIV assay. In: Program and abstracts of the Tenth International Conference on AIDS, August 7-12, 1994; Yokohama, Japan. Abstract 518B/D.
9. Holtgrave DR, Valdiserri RO, Gerber AR, Hinman AR. Human immunodeficiency virus counseling, testing, referral, and partner notification services: A cost-benefit analysis. Archives of Internal Medicine 1993;153:1225-1230.
10. Hun HF, Bettinger CJ, Gallaher MM, Keller NM, Wilson J, Mertz GJ. Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic. JAMA 1988;260:935-38.
11. Siegel K, Levine MP, Brooks C, Kern R. The motives for gay men for taking or not taking the HIV antibody test. Social Problems 1989;36:368-383.
12. Centers for Disease Control and Prevention. Interpretation and use of the western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR 1989;38(No. S-7:[inclusive page numbers].
13. Centers for Disease Control and Prevention. HIV counseling and testing services from public and private providers - United States, 1990. MMWR 1992;41:743-752.
14. U.S. Bureau of Labor Statistics. Employment and Earnings. Washington, DC: U.S. Government Printing Office, January, 1993.
15. Jahn M. A precarious balance on the shaky dollar. Medical Laboratory Observer 1993;25:24-29.
16. McCarthy BD, Wong JB, Munoz A, Sonnenberg FA. Who should be screened for HIV infection. A cost-effectiveness analysis. Arch Intern Med 1993;153:1107-1116.
17. Nahmias S, Feinstein CD. Screening strategies to inhibit the spread of AIDS. Socioecon Plann Sci 1990;24:249-260.
18. McKay NL, Phillips KM. An economic evaluation of mandatory premarital testing for HIV. Inquiry 1991;28:236-248.
19. Petersen LR, White CR, Premarital Screening Study Group. Premarital screening for antibodies to human immunodeficiency virus type 1 in the United States. Am J Public Health 1990;80:1087-1090.
20. Cleary PD, Barry MJ, Mayer KH, Brandt AM, Gostin L, Fineberg HV. Compulsory premarital screening for the human immunodeficiency virus. JAMA 1987;258:1757-1762.
21. Mockler RW, Kleiman MAR. With this test I thee wed: evaluating premarital AIDS testing. J Policy Analysis and Management 1938;7:557-562.
22. Turnock BJ, Kelly CJ. Mandatory premarital testing for human immunodeficiency virus: The Illinois experience. JAMA 1989;261:3415-3418.
23. Gelles GM. Costs and benefits of HIV-1 antibody testing of donated blood. J Policy Analysis and Management 1993;12: 512-531.
24. Eisenstaedt RS, Getzen TE. Screening blood donors for human immunodeficiency virus antibody: Cost-benefit analysis. Am J Public Health 1988;78:450-454.
25. Schwartz JS, Kinosian BP, Pierskalla WP, Lee H. Strategies for screening blood for human immunodeficiency virus antibody. JAMA 1990;264:1704-1710.
26. Bloom DE, Glied S. Benefits and costs of HIV testing. Science 1991;252:1798-1804.
27. Harris RL, Boisaubin EV, Salyer PD, Semands DF Evaluation of a hospital admission HIV antibody voluntary screening program. Infect Control Hosp Epidemiol 1990;11:628-634.
28. Gorsky RD, MacGowan RJ, Swanson NM, DelGado BP. Prevention of HIV infection in drug abusers: A cost analysis. Preventive Medicine 1995;24:3-8.
29. Hedlund K, Spencer J, Schalla W et al. Estimated public costs of HIV counseling and testing. In: Program and abstracts of the Sixth International Conference on AIDS, June 20-24, 1990; San Francisco, CA. Abstract FD835.
30. Phillips KA, Coates TJ, Eversley RB, Catania JA. Who plans to be tested for HIV or would get tested if no one could find out the results? Am J Prev Med 1995;11:156-62.
31. Higgins DL, Galavotti C, O'Reilly KR, et al. Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA 1991;266:2419-2429.
32. Holtgrave DR, Qualls NL, Curran JW, Valdiserri RO, Guinan ME, Parra WC. An overview of the effectiveness and efficiency of HIV prevention programs. Public Health Reports 1995;110:134-146
33. Marwick C. Home testing kits for HIV apt to get FDA approved JAMA. 1995;273:908-909.